SFM
ALXN

Systematic Financial Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Systematic Financial Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35
Closed -$5K – 252
2020
Q4 		$5K Sell
35
-78
-69% -$10K ﹤0.01% 242
2020
Q3 		$13K Hold
113
– – ﹤0.01% 228
2020
Q2 		$13K Hold
113
– – ﹤0.01% 490
2020
Q1 		$10K Hold
113
– – ﹤0.01% 468
2019
Q4 		$12K Sell
113
-312
-73% -$33.4K ﹤0.01% 481
2019
Q3 		$42K Sell
425
-28,633
-99% -$3.23M ﹤0.01% 498
2019
Q2 		$3.81M Sell
29,058
-33,299
-53% -$4.29M 0.15% 148
2019
Q1 		$8.43M Sell
62,357
-65,551
-51% -$8.15M 0.29% 121
2018
Q4 		$12.5M Buy
127,908
+12,173
+11% +$1.44M 0.38% 94
2018
Q3 		$16.1M Buy
115,735
+63,584
+122% +$7.98M 0.39% 85
2018
Q2 		$6.47M Buy
+52,151
New +$6.09M 0.16% 198

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return